Loading annual review details
AeroVironment, Inc. (AVAV)FY2026 investor yearly review
Across FY2026, management framed Blue Halo integration as the catalyst to broaden AeroVironment’s multi-domain offering and accelerate scaling. Q1 and Q2 emphasized strong starts and rising backlog visibility, but Q3 reflected revenue timing and the SCAR stop-work disruption. Q4 then delivered a record quarter and restored profitability direction, while guidance for FY2027 assumed continued funding timing uncertainty.
Overall investor read
Mixed, integration-driven growth with timing risk
Strong FY revenue and Q4 delivery were tempered by Q3 timing issues and SCAR-related impacts disclosed by management.
Primary financial signal
Record Q4 momentum drove full-year profitability
Management highlighted record Q4 revenue and strong adjusted EBITDA versus earlier quarters, alongside improved mix as volume shifted to Q4.
Primary call signal
$1.1B funded backlog with “visibility” improving into year-end
Management repeatedly tied outlook credibility to backlog visibility through the year, while noting task orders and funding timing could move results.
Selected FY2026 outcomes and investor-relevant quality indicators from management’s full-year narrative.
Revenue
FY growth of 1.4%, with Q4 strength lifting the year profile.
Gross margin
Margin pressure earlier in the year contrasted with improved Q4 mix.
Operating margin
Operating margin remained negative through the integration and mix transition.
Net income
Net loss reflected acquisition-era accounting impacts and Q3/SCAR-related items.
Diluted EPS
Diluted EPS remained negative over the full year despite record Q4.
Free cash flow
Full-year FCF stayed negative; Q4 cash rebounded but did not flip the year.
Operating cash flow
Operating cash flow was negative, linked to working-capital needs during scaling.
R&D expense
R&D intensity was reduced year over year as management leaned into commercialization.
Blue Halo integration and scaling capacity dominated the first half, SCAR/rate timing disrupted Q3 expectations, then Q4 execution restored momentum into FY2027.
Integration execution
In Q1 and Q2, management positioned Blue Halo as expanding AeroVironment into space, counter UAS, directed energy, and cyber, with integration “ahead of plan.” Through Q3, they shifted emphasis toward transitioning programs to a more commercial cadence, and in Q4 reiterated portfolio diversification as a key demand tailwind.
Quarter-by-quarter materiality and tone for annual transcript themes.
Scroll horizontally to see more columns.
| Theme | Q1 | Q2 | Q3 | Q4 | Next monitor |
|---|---|---|---|---|---|
| Blue Halo integration broadens space, counter-UAS, and cyber platform | Positive Blue Halo-inclusive Q1 momentum and integration progress ahead of plan |
Management sustained a strong integration-led growth posture and improved execution into Q4, while timing/funding mechanics and SCAR disruptions continued to create uneven conversion and margin volatility.
Management attributed the record Q4 adjusted EBITDA and stronger adjusted gross margins to sales volume picking up and a more favorable mix in the back half.
In Q4, management said it streamlined Switchblade acceptance to shorten the cash conversion cycle, contributing to positive free cash flow in the quarter.
Visibility to the revenue guidance midpoint increased from 82% in Q1 to 93% in Q2 and 98% in Q3, supporting confidence even during disruptions.
FY2026 began with a Blue Halo-inclusive record Q1, moved through Q2 resilience amid shutdown/ERP issues, saw a Q3 timing miss tied to space adjustments and SCAR, then finished with record Q4 execution and profitability expansion.
Q4 rebound after earlier conversion headwinds
Product breakdown bars are scaled against the largest annual revenue item; labels show revenue, YoY change, and revenue share.
Regional breakdown bars are scaled against the largest annual revenue item; labels show revenue, YoY change, and revenue share.
Q1 established Blue Halo-inclusive momentum and backlog visibility, Q2 reinforced bookings and capacity investments despite shutdown/ERP margin headwinds, Q3 introduced timing/SCAR disruption that lowered guidance, and Q4 demonstrated record delivery and repositioned the story for FY2027 under funding uncertainty.
Management highlighted a first quarter inclusive of Blue Halo and described record revenue, bookings, and funded/unfunded backlog. They maintained FY2026 revenue guidance and emphasized visibility to the midpoint while warning task-order timing could still be fluid.
Read earnings transcriptEven with the government shutdown and ERP go-live inefficiencies, management reported record awards and revenue and raised the lower end of FY2026 guidance. They framed margin headwinds as transitional and expected improvement in later quarters if product mix shifted.
FY2026 guidance was maintained early and then revised later; the transcript set guidance is directional/quarter-specific but partially measurable via financial_context actuals.
$1.9B to $2.0B; $100M to $320M (adjusted EBITDA)
Revenue $1.98B; Other not_available
Q1 maintained a wide revenue range and directional profitability optimism, but full-year EPS outcomes ultimately diverged versus early non-GAAP expectations.
$1.95B to $2.0B; $300M to $320M (adjusted EBITDA)
Revenue $1.98B; Other not_available
Management raised the revenue floor but linked the outlook to shutdown timing; revenue landed near the middle, while EPS did not track.
These items were repeatedly emphasized in Q&A and management prepared remarks as the biggest levers for conversion, margin, and durability into FY2027.
Management repeatedly linked conversion to when budgets and task orders are approved and issued, affecting quarterly revenue cadence.
Track visibility language, funded vs unfunded backlog changes, and references to continuing resolution or delayed accounts.
Space segment disruption around SCAR termination for convenience created impairment and shifted near-term revenue and cash cadence.
Backlog & visibility
Management repeatedly used visibility metrics to support guidance credibility: Q1 cited 82% visibility, Q2 increased that to 93%, and Q3 reported 98% visibility versus revised guidance. Even with improving visibility, they repeatedly cautioned that shutdown and government funding approval timing could shift revenue conversion between quarters.
Margin & execution risk
Q3 framed results as below expectations due to revenue timing and space-business adjustments, including SCAR stop-work. Management later described a $151M impairment trigger and then in Q4 discussed incremental goodwill impairment tied to SCAR termination mechanics. They emphasized transitioning phased-array BADGER and other offerings to commercial product models to improve profitability over time.
Scale & profitability
While Q1 and Q2 established strong starts, Q3 highlighted margin and timing pressure (including shipping/supply-chain pushes into Q4). In Q4, management reported record revenue, stronger adjusted gross margins, and referenced improved mix and scale as drivers, along with cash conversion improvements tied to streamlining Switchblade acceptance processes.
AV Halo and product launches framed as integration working
Positive Q4 reiterated diversified portfolio and continued scaling of acquisitions |
| Track how AV_Halo modules, Titan, and LOCUST commercialization cadence show up in quarterly margin and bookings. |
| Government funding and task-order timing drives quarter-to-quarter conversion | Mixed Visibility cited, but continuing resolution and timing risk remained | Mixed Shutdown pushed funded/unfunded conversion; managers kept guidance | Negative Revenue missed expectations as government funding delays shifted orders | Mixed FY2027 guidance reflected continued assumption of delayed funding approvals | Watch “visibility” commentary, funded vs unfunded backlog, and acceptance-testing language affecting revenue cadence. |
| SCAR stop-work and termination mechanics reshaped Q3 and impairment narrative | Negative SCAR stop-work triggered impairment and shifted space expectations | Mixed Incremental goodwill impairment tied to termination for convenience | Monitor space backlog composition changes excluding SCAR, and whether commercialization milestones in BADGER restore margins. |
| Q4 record revenue and gross-margin expansion validated scaling and mix shifts | Positive First-quarter records set expectations for improved adjusted margins | Mixed ERP go-live and shutdown impacts pressured adjusted gross margins | Negative Margins hit by late shipping/supply-chain issues and service mix | Positive Adjusted gross margins peaked; record Q4 volume drove profitability | Track adjusted gross margin trajectory (product vs service mix) and Q4-like volume/acceptance improvements. |
| Commercialization of phased arrays and directed energy targets higher long-term | Positive BADGER shifted toward firm fixed price commercialization profile | Mixed Space Force paused then terminated for convenience; AV moved to commercial model | Positive Management tied future profitability to commercialized Space & Directed Energy | Watch discussions of firm fixed price transition, and whether LOCUST/laser communications show scale with improved margins. |
| Salt Lake City capacity expansion underpins scale story across franchises | Positive Plans for Salt Lake City facility highlighted for demand beyond 2027 | Positive Switchblade facility timeline and production potential reinforced | Positive Q4 linked production capacity investments to FY2027 growth and cash cadence | Monitor when Salt Lake City production starts and how it translates into Switchblade/Red Dragon output and margins. |
Across Q1-Q2, management outlined Salt Lake City capacity expansion, and in Q4 tied production infrastructure investment to FY2027 growth and scaling readiness.
Management said results were below expectations in Q3, primarily driven by revenue timing and adjustments made in the space business as orders shifted later.
Q3 described SCAR stop-work as a trigger for a $151M goodwill impairment, and Q4 added an incremental impairment tied to termination for convenience mechanics.
Management cited Oracle Fusion ERP go-live inefficiencies and government shutdown impacts (including product/service mix and delayed FMS shipments) as margin headwinds in Q2.
For FY2027, management explicitly did not assume early funding arrival and framed revenue/EBITDA guidance in the context of continuing resolution dynamics into December/January.
Scroll horizontally to see more columns.
| Quarter | Revenue | YoY revenue growth | Diluted EPS | Gross margin | Investor read |
|---|---|---|---|---|---|
| Q1Aug-25 | $454.68M | 65.3% | $-2.39 | 20.9% | Record Q1 revenue and backlog visibility supported FY2026 confidence, but timing risk stayed central after the Blue Halo integration. |
| Q2Nov-25 | $472.51M | 3.9% | $-0.34 | 17.4% | Q2 balanced strong bookings and guidance raises with gross-margin pressure from shutdown and ERP transition inefficiencies. |
| Q3Jan-26 | $408.05M | -13.6% | $-3.15 | 17.1% | Q3 reset expectations—SCAR and shifted order timing drove a guidance cut—yet backlog strengthened for a record Q4. |
| Q4Apr-26 | $641.62M | 57.2% | $1.25 | 39.6% | Record Q4 capped the year; management linked Q4 profitability to mix improvements and set FY2027 guidance under funding timing uncertainty. |
Management described Q3 as below expectations, attributing it to revenue timing plus space-business adjustments including SCAR stop-work. They lowered full-year guidance and emphasized order flow and backlog building to support a record Q4 and a stronger FY2027 start.
Read earnings transcriptManagement delivered record Q4 revenue and strong adjusted EBITDA, citing sales volume and mix improvement as drivers. They also discussed SCAR termination-related impairment mechanics and provided FY2027 guidance that assumed continued uncertainty in early funding timing.
Read earnings transcript$1.85B to $1.95B; $265M to $285M (adjusted EBITDA)
Revenue $1.98B; Other not_available
Q3 guidance lowered due to space/SCAR disruptions, yet actual FY revenue exceeded the revised range’s midpoint—consistent with Q4 catch-up commentary.
Not available
Revenue $1.98B; Other not_available
Q4 focused more on reported records and FY2027 outlook rather than reissuing measurable FY2026 guidance ranges in the transcript.
Watch space backlog composition excluding SCAR and any updates on commercialization milestones that management tied to profitability.
LOCUST was discussed as moving from early adoption to larger market opportunities, with milestones tied to adoption cycle timing.
Monitor LOCUST production expansion commentary (milestones, manufacturing investments) and how it affects adjusted gross margin.
Management highlighted cash conversion cycle extension from acceptance testing and then Q4 process streamlining as a turning point.
Listen for updates to acceptance process improvements and whether Q4-like free cash flow behavior sustains.
Dafinchi